Comparison of Ranibizumab and Bevacizumab for Macular Edema Associated with Branch Retinal Vein Occlusion
Bo Kwon Son, Hyung Woo Kwak, Eung Suk Kim, Seung-Young Yu
Korean J Ophthalmol. 2017;31(3):209-216.   Published online 2017 Apr 24     DOI: https://doi.org/10.3341/kjo.2015.0158
Citations to this article as recorded by Crossref logo
A Multicenter, Retrospective Study (RE-ENACT 2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion
Shashikant Sharma, Mujtaba Khan, Alok Chaturvedi
Ophthalmology and Therapy.2020; 9(3): 625.     CrossRef
A systematic review of real-world evidence of the management of macular oedema secondary to branch retinal vein occlusion
Juan Lyn Ang, Sarah Ah-Moye, Leah N. Kim, Vuong Nguyen, Adrian Hunt, Daniel Barthelmes, Mark C. Gillies, Hemal Mehta
Eye.2020; 34(10): 1770.     CrossRef
A comparison of the effect of intravitreal dexamethasone implant on macular and branch retinal vein occlusion. A real life experience
Ozkan Sever, Akin Cakir, Fatih Horozoglu
European Journal of Ophthalmology.2020; 30(5): 1106.     CrossRef
A Comparison of Three Intravitreal Modalities of Branch Retinal Vein Occlusion Macular Edema
Han Song, Hee Jun Song, Ji Ho Yang, Do Gyun Kim
Journal of the Korean Ophthalmological Society.2018; 59(9): 834.     CrossRef
Predictive Factors for a Favorable Response to Intravitreal Bevacizumab for Macular Edema Associated with Branch Retinal Vein Occlusion
Hyun Goo Kang, Yuri Seo, Eun Young Choi, Sung Chul Lee, Min Kim
Journal of Retina.2018; 3(1): 20.     CrossRef